Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea
· Delayed Price · Currency is KRW 1,139.00
-14.00 (-1.21%)
Jun 19, 2025, 3:30 PM KST
Enzychem Lifesciences Revenue
Enzychem Lifesciences had revenue of 20.78B KRW in the quarter ending March 31, 2025, a decrease of -6.57%. This brings the company's revenue in the last twelve months to 75.92B, down -8.15% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.
Revenue (ttm)
75.92B
Revenue Growth
-8.15%
P/S Ratio
1.18
Revenue / Employee
597.77M
Employees
127
Market Cap
89.51B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |